Sort by:
Highly potent EGFR-kinase inhibitor
Orally active, selective EGFR inhibitor
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor
Potent, reversible EGFR tyrosine kinase inhibitor
EGFR kinase inhibitor. Also estrogen and PPARγ ligand
Negative control for PP 2 (Cat. No. 1407)
Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor
Selective ErbB2 inhibitor
Potent dual EGFR/ErbB2 inhibitor; orally active
Potent ErbB receptor family inhibitor
Potent ErbB receptor family inhibitor
Potent and selective ErbB2 inhibitor
Potent EGFR-kinase inhibitor
Potent EGFR and VEGFR inhibitor
Potent EGFR kinase inhibitor
Potent irreversible pan ErbB inhibitor
Potent mutant-selective EGFR inhibitor
Potent and irreversible EGFR inhibitor; orally bioavailable
Potent dual specificity EGFR/HER2 inhibitor; active in vivo
Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors
Potent HER2 receptor tyrosine kinase and EGFR kinase inhibitor
Inhibitor of EGFR mutants
Potent VEGFR-2 inhibitor, also inhibits EGFR and RET oncoproteins activity
Potent and selective ErbB2 inhibitor